SREBF2 and metabolic dysfunction-associated steatotic liver disease: Microcystin-LR Drives Early NAFLD Pathogenesis via Hepatic Cholesterol Accumulation: Dysregulation of &lt;i&gt;Ldlr&lt;/i&gt; and &lt;i&gt;Abcg1&lt;/i&gt; Expression Uncoupled from &lt;i&gt;Srebp2&lt;/i&gt;.